Wellington Shields & Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $72.5K | Sell |
1,384
-59
| -4% | -$3.12K | 0.02% | 299 |
|
|
2026
Q1 | $79.6K | Hold |
1,443
| – | – | 0.02% | 286 |
|
|
2025
Q4 | $70.8K | Sell |
1,443
-264
| -15% | -$12.3K | 0.02% | 290 |
|
|
2025
Q3 | $73.7K | Buy |
+1,707
| New | +$66.7K | 0.02% | 290 |
|
|
2024
Q4 | – | Sell |
-2,379
| Closed | -$97.3K | – | 302 |
|
|
2024
Q3 | $97.3K | Hold |
2,379
| – | – | 0.03% | 262 |
|
|
2024
Q2 | $91.6K | Hold |
2,379
| – | – | 0.03% | 253 |
|
|
2024
Q1 | $102K | Hold |
2,379
| – | – | 0.03% | 248 |
|
|
2023
Q4 | $88.2K | Sell |
2,379
-880
| -27% | -$31.6K | 0.03% | 247 |
|
|
2023
Q3 | $118K | Sell |
3,259
-1,066
| -25% | -$37.8K | 0.03% | 233 |
|
|
2023
Q2 | $154K | Hold |
4,325
| – | – | 0.04% | 223 |
|
|
2023
Q1 | $154K | Buy |
4,325
+59
| +1% | +$2.06K | 0.03% | 223 |
|
|
2022
Q4 | $150K | Hold |
4,266
| – | – | 0.03% | 224 |
|
|
2022
Q3 | $126K | Hold |
4,266
| – | – | 0.06% | 216 |
|
|
2022
Q2 | $232K | Sell |
4,266
-1,760
| -29% | -$97.2K | 0.06% | 180 |
|
|
2022
Q1 | $328K | Buy |
6,026
+800
| +15% | +$43.5K | 0.11% | 157 |
|
|
2021
Q4 | $288K | Sell |
5,226
-640
| -11% | -$33.3K | 0.06% | 174 |
|
|
2021
Q3 | $280K | Buy |
5,866
+400
| +7% | +$20.1K | 0.1% | 166 |
|
|
2021
Q2 | $272K | Hold |
5,466
| – | – | 0.09% | 164 |
|
|
2021
Q1 | $244K | Sell |
5,466
-1,600
| -23% | -$72.6K | 0.09% | 167 |
|
|
2020
Q4 | $325K | Sell |
7,066
-2,320
| -25% | -$107K | 0.12% | 129 |
|
|
2020
Q3 | $442K | Hold |
9,386
| – | – | 0.19% | 101 |
|
|
2020
Q2 | $479K | Hold |
9,386
| – | – | 0.21% | 96 |
|
|
2020
Q1 | $445K | Hold |
9,386
| – | – | 0.25% | 94 |
|
|
2019
Q4 | $551K | Buy |
+9,386
| New | +$522K | 0.24% | 93 |
|
|
2019
Q3 | – | Sell |
-9,386
| Closed | -$470K | – | 144 |
|
|
2019
Q2 | $470K | Sell |
9,386
-160
| -2% | -$8.03K | 0.22% | 104 |
|
|
2019
Q1 | $499K | Hold |
9,546
| – | – | 0.25% | 97 |
|
|
2018
Q4 | $456K | Sell |
9,546
-134
| -1% | -$6.6K | 0.26% | 95 |
|
|
2018
Q3 | $486K | Sell |
9,680
-1,000
| -9% | -$50.8K | 0.26% | 86 |
|
|
2018
Q2 | $538K | Buy |
10,680
+1,160
| +12% | +$58.4K | 0.28% | 78 |
|
|
2018
Q1 | $465K | Buy |
9,520
+3,840
| +68% | +$179K | 0.25% | 86 |
|
|
2017
Q4 | $252K | Sell |
5,680
-4,080
| -42% | -$188K | 0.14% | 130 |
|
|
2017
Q3 | $495K | Buy |
9,760
+2,400
| +33% | +$122K | 0.16% | 82 |
|
|
2017
Q2 | $397K | Hold |
7,360
| – | – | 0.14% | 84 |
|
|
2017
Q1 | $388K | Sell |
7,360
-400
| -5% | -$20.3K | 0.12% | 78 |
|
|
2016
Q4 | $374K | Hold |
7,760
| – | – | 0.2% | 80 |
|
|
2016
Q3 | $418K | Buy |
7,760
+160
| +2% | +$8.77K | 0.21% | 66 |
|
|
2016
Q2 | $412K | Buy |
7,600
+800
| +12% | +$42.1K | 0.26% | 62 |
|
|
2016
Q1 | $345K | Hold |
6,800
| – | – | 0.23% | 68 |
|
|
2015
Q4 | $343K | Buy |
+6,800
| New | +$347K | 0.23% | 65 |
|
Other funds holding GSK
JEST
Wellington Shields & Co's GSK Position: Q2 2026 in Review
Wellington Shields & Co reduced its GSK (GSK) stake by 4.1% in Q2 2026, selling an estimated $3.12K and leaving 1,384 shares worth $72.5K. The position accounts for 0.02% of the portfolio, ranked #299.
Wellington Shields & Co first reported a position in GSK in Q4 2015 and has held it in 39 quarters since. The position peaked at $551K in Q4 2019. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Wellington Shields & Co held 1,384 shares of GSK worth $72.5K as of Q2 2026.
- Wellington Shields & Co sold 59 GSK shares in Q2 2026, an estimated $3.12K.
- GSK made up 0.02% of Wellington Shields & Co's portfolio in Q2 2026, its #299 holding.
- Wellington Shields & Co first reported a position in GSK in Q4 2015 and has held it in 39 quarters since.
- Wellington Shields & Co's GSK position peaked at $551K in Q4 2019.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.